Iowa’s Terpenoid Therapeutics raises $950,000 for cancer drugs

Terpenoid is developing two drugs — one to treat metastatic bone disease associated with prostate and breast cancer and multiple myeloma, and the second to treat brain cancers.

[Read more of this report]


ADHD drug developer KemPharm raises nearly $3.5 million

Its lead drug lasts longer in the body than many ADHD treatments and won’t produce the same “high” if recreationally snorted or injected.

[Read more of this report]


Grassley doubtful about Democrat-led health care reform — MedCity Morning Read, Aug. 26, 2009

Sen. Chuck Grassley signaled growing skepticism about the likelihood of Democrat-led health care reform passing this year at a town hall meeting on Monday. Sen. John McCain said during a town hall meeting in Sun City, Ariz., on Tuesday that creation of a government-run health plan would threaten the quality of medical care and pit the needs of consumers and older Americans against national interests.

[Read more of this report]


NewLink Genetics raises $7.5 million to continue trials of cancer therapies

NewLink Genetics Corp. has completed its fourth investment round, raising $7.5 million to speed clinical development of its cancer therapies. Both the company’s vaccine and drug are considered “immunotherapies” because they work by helping the body’s immune system fight cancer.

[Read more of this report]


Ohio gets high marks for low-cost health policy

Ohio was ranked fourth compared to other states in avoiding high-cost health mandates on businesses, according to a new study by the Small Business and Entrepreneurship Council, a Washington, D.C., advocacy group.

[Read more of this report]


Be a Thought Leader: Join MedCitizens

Anyone can blog on MedCity News when they become a "MedCitizen." MedCitizens publish their own thoughts about current medical news and the latest issues in healthcare to the entire MedCity News audience.

Click to login or learn more

MedCity Twitter Buzz

MedCity Jobs Board

Real Time Web Analytics